Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DexCom, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
DXCM
Nasdaq
3841
https://www.dexcom.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DexCom, Inc.
Nevro (NVRO) Up 15.7% Since Last Earnings Report: Can It Continue?
- Dec 1st, 2023 4:31 pm
2 Strong Stocks Trading 30% Below Their Highs to Buy in December
- Dec 1st, 2023 12:00 pm
Charles River (CRL) Gains on Price & Volume Growth Amid FX Woe
- Nov 30th, 2023 4:17 pm
11 Best Long Term Growth Stocks To Invest In
- Nov 30th, 2023 1:07 pm
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
- Nov 28th, 2023 2:45 pm
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
- Nov 28th, 2023 2:40 pm
Goldman Sachs’ Top 15 Stock Picks for 2024
- Nov 26th, 2023 2:58 pm
Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM)
- Nov 25th, 2023 2:04 pm
Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?
- Nov 23rd, 2023 1:51 pm
EssilorLuxottica (ESLOY), Moncler Ink Luxury Eyewear Deal
- Nov 23rd, 2023 1:49 pm
Here's Why You Should Retain Edward Lifesciences (EW) Stock Now
- Nov 23rd, 2023 11:06 am
DexCom's (NASDAQ:DXCM) 29% CAGR outpaced the company's earnings growth over the same five-year period
- Nov 22nd, 2023 1:26 pm
Dexcom Announces Upcoming Conference Presentation
- Nov 21st, 2023 1:30 pm
3 Growth Stocks to Buy With $1,000 Right Now
- Nov 21st, 2023 11:30 am
DexCom (DXCM) is an Incredible Growth Stock: 3 Reasons Why
- Nov 20th, 2023 5:45 pm
13 Stocks That Outperform the S&P 500 Every Year for the Last 5 Years
- Nov 20th, 2023 4:56 pm
Zacks.com featured highlights include DexCom, Arthur J. Gallagher, Limbach and The Hartford Financial Services
- Nov 20th, 2023 1:56 pm
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
- Nov 20th, 2023 11:03 am
Investors’ Concerns over the Impact of GLP-1 Drugs Dragged DexCom (DXCM)
- Nov 20th, 2023 6:33 am
2 Stock Split Growth Stocks to Buy and Hold
- Nov 19th, 2023 2:00 pm
Scroll